Position in SCYX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$474,842
-$196,357 QoQ
Shares Held
116,669
+27.5% QoQ
Ownership
1.17%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 39 holders
Holding Since
Jun 2021
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCYX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $533,943,071 across 32 Drug Manufacturers - Specialty & Generic names. SCYX ranks #26 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
318,320 | $172,475,325 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
441,371 | $74,388,668 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
679,083 | $43,427,357 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
2,260,243 | $32,750,921 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
733,974 | $30,114,953 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
1,650,255 | $28,565,914 | |
| 7 | BHC |
Bausch Health Companies Inc.
|
5,482,986 | $27,031,120 | |
| 8 | ZTS |
Zoetis Inc.
|
364,442 | $26,188,802 |
All Filings in SCYX
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $474,842 | 116,669 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $671,199 | 731,952 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $368,528 | 583,114 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $320,783 | 416,602 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $286,538 | 424,502 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $421,795 | 443,063 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $565,394 | 467,268 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $805,617 | 540,683 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,081,366 | 540,683 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $618,992 | 421,083 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $890,624 | 399,383 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $675,139 | 296,114 | Shares | Defined | 2023-11-13 | |
| 2021-06-30 | $56,362 | 7,658 | Shares | Defined | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||